Human Papillomavirus (HPV)

Recent News

Oct 24, 2018

News Scan for Oct 24, 2018

New DRC Ebola cases
Deadly NJ adenovirus outbreak
Hepatitis A vaccine in homeless
HPV vaccine messaging
Oct 08, 2018

News Scan for Oct 08, 2018

FDA approves expanded Gardasil use
Cholera cases rise in Zimbabwe and Niger
Aug 24, 2018
Throat exam

CDC: Mouth area now most common site of HPV-linked cancer

The oropharyngeal cancer rate increased 2.8% per year in men and 0.6% in women.

Aug 22, 2018

News Scan for Aug 22, 2018

HPV vaccine and premature menopause
Cyclospora expert panel
Aug 21, 2018

News Scan for Aug 21, 2018

HPV and cervical cancer
H7N9 in smuggled poultry
Aug 20, 2018
Couple outdoors man smoking

UK study bolsters HPV infection link to smoking, sexual activity

Former smokers had triple the risk, while those with more than 6 sex partners had a sixfold risk.

Aug 08, 2018
HPV vaccination

Study: Catch-up HPV vaccination effective until age 20

The results confirm, however, that the vaccine is most effective when given at younger ages.

Jul 19, 2018

News Scan for Jul 19, 2018

Low UK flu vaccine protection
FDA mulls sole-source drug supply
Evaluating Ebola vaccine
Ebola medical treatments
HPV vaccine in boys, men
Jun 14, 2018

News Scan for Jun 14, 2018

More suspected DRC Ebola
Salmonella egg outbreak
HPV vaccination messaging
Manure-related E coli illness
May 09, 2018

News Scan for May 09, 2018

More romaine E coli cases
Predicting pandemic severity
Lassa fever cases
HPV vaccine meta-analysis

Resources & Literature

Recent Literature

Amorim AT, Marques LM, Campos GB, et al. Co-infection of sexually transmitted pathogens and human papillomavirus in cervical samples of women of Brazil. BMC Infect Dis 2017 Dec 15;17:769

Arbyn M, Xu L, Simoens C, et al. Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors. Cochrane Database Syst Rev 2018 (published online May 9)

Artemchuk H, Eriksson T, Poljak M, et al. Long-term antibody response to human papillomavirus vaccines: up to 12 years follow-up in the Finnish maternity cohort. J Infect Dis 2018 (published online Sep 18)

Artemchuk H, Triglav T, Ostrbenk A, et al. Seroprevalences for 11 human papillomavirus (HPV) types mark cumulative HPV exposure. J Infect Dis 2018 (published online Feb 26)

Aziz H, Iqbal H, Mahmood H, et al. Human papillomavirus (HPV) infection in females with normal cervical cytology: genotyping and phylogenetic analysis among women in Punjab, Pakistan. Int J Infect Dis 2017 (published online Nov 11)

Boyd ED, Phillips JM, Schoenberger YMM, et al. Barriers and facilitators to HPV vaccination among rural Alabama adolescents and their caregivers. Vaccine 2018 (published online May 21)

Calo WA, Gilkey MB, Malo TL, et al. A content analysis of HPV vaccination messages available online. Vaccine 2018 (published online Oct 23)

Combes JD, Heard I, Poizot-Martin I, et al. Prevalence and risk factors for anal human papillomavirus infection in HIV-positive men having sex with men. J Infect Dis 2018 (published online Jan 31)

Dehlendorff C, Sparen P, Baldur-Felskov B, et al. Effectiveness of varying number of doses and timing between doses of quadrivalent HPV vaccine against severe cervical lesions. Vaccine 2018 (published online Sep 21)

Dempsey AF, Pyrznawoski J, Lockhart, S, et al. Effect of health care professional communication training intervention on adolescent human papillomavirus vaccination. JAMA Pediatr 2018 (published online Mar 5)

Doke K, Fitzgerald SA, Barral RL, et al. Concomitant HPV and MenACWY vaccination among sixth and seventh graders receiving Tdap. Vaccine 2018 (published online Sep 25)

Donken R, King AJ, Bogaards JA, et al. High effectiveness of the bivalent HPV vaccine up to six years post-vaccination against incident and persistent HPV infections in young Dutch females. J Infect Dis 2018 (published online Feb 2)

Fedewa SA, Preiss AJ, Fisher-Borne M, et al. Reaching 80% human papillomavirus vaccination prevalence by 2026: how many adolescents need to be vaccinated and what are their characteristics? CA Cancer J Clin 2018 (published online Sep 26)

Feiring B, Laake I, Christiansen IK, et al. Substantial decline in prevalence of vaccine-type and non-vaccine type HPV in vaccinated and unvaccinated girls 5 years after implementing HPV vaccine in Norway. J Infect Dis 2018 (published online Jul 16)

Gargano JW, Park IU, Griffin MR, et al. Trends in high-grade cervical lesions and cervical cancer screening in five states, 2008-2015. Clin Infect Dis 2018 (published online Aug 23)

Gargano JW, Zhou F, Stokley S, et al. Human papillomavirus vaccination in commercially-insured vaccine-eligible males and females, United States 2007-2014. Vaccine 2018 (published online May 4)

Garland SM, Pitisuttithum P, Ngan HYS, et al. Efficacy, immunogenicity, and safety of a 9-valent human papillomavirus vaccine: subgroup analysis of participants from Asian countries. J Infect Dis 2018 (published online May 15)

Gilca V, Sauvageau C, Panicker G, et al. Immunogenicity and safety of a mixed vaccination schedule with one dose of nonavalent and one dose of bivalent HPV vaccine versus two doses of nonavalent vaccine — a randomized clinical trial. Vaccine 2018 (published online Oct 9)

Guo F, Cofie LE, Berenson AB. Cervical cancer incidence in young U.S. females after human papillomavirus vaccine introduction.  Am J Prev Med 2018 (published online May 30)

Hanson KE, Koch B, Bonner K, et al. National trends in parental HPV vaccination intentions and reasons for hesitancy, 2010-2015. Clin Infect Dis 2018 (published online Mar 27)

Hirth J, McGrath CJ, Kuo YF, et al. Impact of human papillomavirus vaccination on racial/ethnic disparities in vaccine-type human papillomavirus prevalence among 14-26 year old females in the U.S. Vaccine 2018 (published online Oct 28)

Ji Y, Ma XX, Li Z, et al. The burden of human papillomavirus and Chlamydia trachomatis coinfection in women: a large cohort study in Inner Mongolia, China. J Infect Dis 2018 (published online Sep 5)

Kim JJ, Burger EA, Regan C, et al. Screening for cervical cancer in primary care a decision analysis for the US Preventive Services Task Force. JAMA 2018 Aug 21;320(7):706-14

Klooster TM, Kemmeren JM, van der Maas NA, et al. No evidence found for an increased risk of long-term fatigue following human papillomavirus vaccination of adolescent girls. Vaccine 2018 (published online Sep 24)

Kojic EM, Conley L, Bush T, et al. Prevalence and incidence of anal and cervical high-risk human papillomavirus (HPV) types covered by current HPV vaccines among HIV-infected women in the study to understand the natural history of HIV/AIDS in the era of effective therapy (the SUN study). J Infect Dis 2018 (published online Feb 14)

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»


Unrestricted financial support provided by

Bentson Foundation 3MAccelerate DiagnosticsGilead Become an underwriter»